MiniMed Group is a medical technology company that develops, manufactures, and sells insulin pumps, continuous glucose monitoring systems, and related consumables for managing Type 1 and Type 2 diabetes. The company serves patients across more than 80 countries through an integrated ecosystem where proprietary CGM sensors work exclusively with its automated insulin delivery pumps, creating recurring revenue from frequent consumable replacements and periodic pump upgrades while generating premium pricing through this closed-loop system. Revenue comes primarily from CGM products, consumables like infusion sets, and insulin pumps themselves, supported by digital health solutions and patient education services that reinforce customer loyalty and lifetime value.